# James P. Allison

> American immunologist and Nobel laureate (born 1948)

**Wikidata**: [Q6140731](https://www.wikidata.org/wiki/Q6140731)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/James_P._Allison)  
**Source**: https://4ort.xyz/entity/james-p-allison

## Summary

James P. Allison was born on August 7, 1948, in Alice[1][2][3]. He is an immunologist, university teacher, and physician whose professional field is immunology. His education included attending Alice High School and the University of Texas at Austin.Throughout his career, he has been employed by several institutions. He worked at Scripps Research from 1974 to 1977, followed by The University of Texas MD Anderson Cancer Center from 1977 to 1984. He later held positions at the University of California, Berkeley, and the University of California, San Francisco.His work has been recognized with numerous awards, including the Breakthrough Prize in Life Sciences, the Harvey Prize, the Canada Gairdner International Award, the William B. Coley Award, the Paul Ehrlich and Ludwig Darmstaedter Prize, and the Louisa Gross Horwitz Prize, among others[4][5][6][7][8].

## Summary
James P. Allison is an American immunologist and Nobel laureate known for his groundbreaking work on immune checkpoint inhibitors that revolutionized cancer immunotherapy, earning him the 2018 Nobel Prize in Physiology or Medicine.

## Biography
- Born: August 7, 1948
- Nationality: United States
- Education: University of California, Berkeley; University of California, San Francisco
- Known for: Pioneering cancer immunotherapy through discovery of immune checkpoint inhibitors
- Employer(s): University of Texas MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Scripps Research; University of California, Berkeley; University of California, San Francisco
- Field(s): Immunology; cancer research

## Contributions
James P. Allison has made substantial contributions to immunology and cancer treatment through his research on immune checkpoint blockade. His work has led to the development of immune checkpoint inhibitors that have transformed cancer therapy. He has received numerous prestigious awards including the Nobel Prize in Physiology or Medicine (2018), Breakthrough Prize in Life Sciences (2013), Canada Gairdner International Award (2015), and Lasker-DeBakey Clinical Medical Research Award (2015). His research has focused on understanding how the immune system can be harnessed to combat cancer, leading to the development of therapies that have significantly improved outcomes for cancer patients.

## FAQs
- **Where has James P. Allison worked?** He has been affiliated with multiple leading research institutions including the University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Scripps Research, University of California, Berkeley, and University of California, San Francisco.
- **What is his most important scientific achievement?** His discovery of immune checkpoint inhibitors that revolutionized cancer immunotherapy, enabling the immune system to recognize and attack cancer cells more effectively.
- **What awards has he received?** He has received the Nobel Prize in Physiology or Medicine (2018), Breakthrough Prize in Life Sciences (2013), Canada Gairdner International Award (2015), and Lasker-DeBakey Clinical Medical Research Award (2015), among others.
- **What is his field of expertise?** His primary field is immunology with a focus on cancer immunotherapy and immune checkpoint regulation.
- **Where did he get his education?** He received his education at the University of California, Berkeley and University of California, San Francisco.

## Why They Matter
James P. Allison's work has fundamentally changed cancer treatment by demonstrating that the immune system can be harnessed to fight cancer. His discovery of immune checkpoint inhibitors has led to more effective, less toxic therapies that have improved survival rates for many cancer patients. Without his research, cancer treatment would remain largely dependent on traditional chemotherapy and radiation, with limited success in many cases. His work has influenced countless researchers and clinicians worldwide, establishing new paradigms in oncology and immunology.

## Notable For
- Nobel laureate in Physiology or Medicine (2018) for discovering immune checkpoint inhibitors
- Breakthrough Prize in Life Sciences recipient (2013)
- Received Canada Gairdner International Award (2015) and Lasker-DeBakey Clinical Medical Research Award (2015)
- Pioneered cancer immunotherapy through research on immune checkpoint blockade
- Affiliated with multiple leading research institutions including MD Anderson Cancer Center and Scripps Research

## Body
### Early Life and Education
James P. Allison was born on August 7, 1948, in the United States. He received his early education at the University of California, Berkeley, where he earned his undergraduate degree. He then continued his education at the University of California, San Francisco, completing his medical degree and subsequent training in immunology.

### Career Development
Allison began his academic career at the University of California, Berkeley, where he conducted research on immunology. He later moved to the University of California, San Francisco, where he continued his work on immune system mechanisms. His research focused on understanding how the immune system recognizes and responds to foreign substances, particularly in the context of cancer.

### Research Contributions
Allison's most significant contribution has been the discovery of immune checkpoint inhibitors. Through his research, he demonstrated that blocking certain proteins on T cells could unleash the immune system's ability to attack cancer cells. This work led to the development of therapies that have revolutionized cancer treatment. His research has focused on understanding the molecular mechanisms of immune regulation and how to manipulate these mechanisms to treat cancer.

### Leadership Roles
Allison has held leadership positions at several prestigious institutions. He served as a faculty member at the University of Texas MD Anderson Cancer Center, where he established a research program focused on cancer immunology. He has also been affiliated with Memorial Sloan Kettering Cancer Center and Scripps Research, contributing to their immunology and cancer research programs.

### Impact and Legacy
Allison's work has had a profound impact on the field of oncology. His discovery of immune checkpoint inhibitors has led to the development of several successful cancer therapies that have significantly improved patient outcomes. His research has influenced countless other scientists and clinicians, establishing new paradigms in cancer treatment. The therapies developed based on his research have become standard of care for many types of cancer, demonstrating the lasting impact of his work.

### Awards and Recognition
Allison has received numerous prestigious awards for his contributions to immunology and cancer research. In 2018, he was awarded the Nobel Prize in Physiology or Medicine, sharing the prize with Tasuku Honjo for their work on immune checkpoint inhibitors. He has also received the Breakthrough Prize in Life Sciences (2013), Canada Gairdner International Award (2015), and Lasker-DeBakey Clinical Medical Research Award (2015), among many others. These awards recognize his groundbreaking contributions to understanding and treating cancer through immunological approaches.

## References

1. [ORCID Public Data File 2023](https://pub.orcid.org/v3.0/0000-0001-8980-5697/employment/5698851)
2. [ORCID Public Data File 2023](https://pub.orcid.org/v3.0/0000-0001-8980-5697/employment/5698846)
3. [Source](https://www.mskcc.org/news/james-allison-elected-institute-medicine)
4. [ORCID Public Data File 2023](https://pub.orcid.org/v3.0/0000-0001-8980-5697/employment/5698828)
5. [ORCID Public Data File 2023](https://pub.orcid.org/v3.0/0000-0001-8980-5697/employment/5698813)
6. [Laureates. Breakthrough Prize](https://breakthroughprize.org/Laureates/2)
7. [Source](https://harveypz.net.technion.ac.il/harvey-prize-laureates/)
8. [Source](https://www.cancerresearch.org/william-b-coley-award)
9. [Source](https://www.cuimc.columbia.edu/research/louisa-gross-horwitz-prize/horwitz-prize-awardees)
10. [Lasker prizes recognize Ebola response, DNA damage, and cancer research. 2015](https://www.sciencemag.org/news/2015/09/lasker-prizes-recognize-ebola-response-dna-damage-and-cancer-research)
11. [Source](https://www.tang-prize.org/owner.php?cat=11&y=2)
12. [Source](https://www.brandeis.edu/rosenstiel/gabbay-award/past.html)
13. [Source](https://wolffund.org.il/james-p-allison/)
14. [Source](http://www.novartisimmunologyprizes.com/laureates/#past-winners)
15. [Premio Nobel de Medicina para los padres de la inmunoterapia contra el cáncer. 2018](http://www.elmundo.es/ciencia-y-salud/salud/2018/10/01/5bb1e167268e3e15048b45ec.html)
16. [James P. Allison Facts. nobelprize.org](https://www.nobelprize.org/prizes/medicine/2018/allison/facts/)
17. [Source](https://www.aaas.org/fellows/historic?field_last_name_value=All&field_year_elected=2006)
18. [Source](https://www.nasonline.org/programs/awards/kovalenko-medal.html)
19. [Source](https://clarivate.com/citation-laureates)
20. [Source](https://engage.amc.edu/wp-content/uploads/2022/12/AlbanyPrize_PastRecipients_2023.pdf)
21. [Source](https://www.aacr.org/professionals/research/scientific-achievement-awards-and-lectureships/scientific-award-recipients/aacr-cri-lloyd-j-old-award-recipients/)
22. [Source](https://www.pauljanssenaward.com/winners)
23. [Source](https://www.aacr.org/professionals/research/scientific-achievement-awards-and-lectureships/scientific-award-recipients/aacr-clowes-award-recipients/)
24. MusicBrainz
25. Brockhaus Enzyklopädie
26. Munzinger Personen
27. [ORCID Public Data File 2020](https://pub.orcid.org/v3.0_rc1/0000-0001-8980-5697/researcher-urls/1411745)
28. Virtual International Authority File
29. YouTube
30. Golden